Homologous recombination repair gene alterations occur across cutaneous adnexal carcinoma subtypes: a genomic cohort analysis, scoping review, and case report

Background Cutaneous adnexal carcinomas are rare malignancies without an approved systemic therapy for metastatic disease. Alterations in homologous recombination repair (HRR) genes confer sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors in other tumors, but their frequency in adnexal carcinomas is unknown. Existing evidence comes largely from case reports and small series limited to single tumor subtypes. Methods To estimate the prevalence of somatic and germline HRR alterations across adnexal carcinoma subtypes, we queried the Tempus Lens database. We supplemented this analysis with a scoping review of PubMed and Scopus for reports of ATM, CHEK2, PALB2, BRCA1, BRCA2, or RAD51 alterations in adnexal carcinomas. We also included a case of digital papillary adenocarcinoma, a subtype not previously represented in this literature, harboring a germline ATM variant. Results In the Tempus cohort (81 patients), 20 tumors (24.7%) carried at least one somatic HRR mutation, including 50.0% of sebaceous adenocarcinomas, and 5 of 36 patients with germline data (13.9%) carried an HRR variant. In the scoping review, 14 studies met inclusion criteria, of which 13 reported patient-level data on 41 patients. Including our case, 42 patients with 60 gene-level alterations were analyzed. BRCA1 was reported most often (38.1%), followed by BRCA2 (35.7%) and ATM (33.3%). Alterations spanned sebaceous, apocrine, eccrine, and follicular differentiation; sebaceous-lineage tumors accounted for 32 alterations (53.3%) and porocarcinoma for 18 (30.0%). Conclusion HRR alterations occur across multiple adnexal carcinoma subtypes, supporting consideration of somatic and germline testing in advanced disease. Whether these alterations predict benefit from PARP inhibition remains to be established.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-18
DOI
https://doi.org/10.3389/fonc.2026.2014671
Primary Topic
Cancer and Skin Lesions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Homologous recombination repair gene alterations occur across cutaneous adnexal carcinoma subtypes: a genomic cohort analysis, scoping review, and case report

Ahmad A. Rajeh, MacKenzie Poole, Alice Yao Zhou, Blake Sparkman
3 links
Frontiers in Oncology
Cancer and Skin Lesions
article

Homologous recombination repair gene alterations occur across cutaneous adnexal carcinoma subtypes: a genomic cohort analysis, scoping review, and case report

Ahmad A. Rajeh, MacKenzie Poole, Alice Yao Zhou, Blake Sparkman
article en

Abstract

Background Cutaneous adnexal carcinomas are rare malignancies without an approved systemic therapy for metastatic disease. Alterations in homologous recombination repair (HRR) genes confer sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors in other tumors, but their frequency in adnexal carcinomas is unknown. Existing evidence comes largely from case reports and small series limited to single tumor subtypes. Methods To estimate the prevalence of somatic and germline HRR alterations across adnexal carcinoma subtypes, we queried the Tempus Lens database. We supplemented this analysis with a scoping review of PubMed and Scopus for reports of ATM, CHEK2, PALB2, BRCA1, BRCA2, or RAD51 alterations in adnexal carcinomas. We also included a case of digital papillary adenocarcinoma, a subtype not previously represented in this literature, harboring a germline ATM variant. Results In the Tempus cohort (81 patients), 20 tumors (24.7%) carried at least one somatic HRR mutation, including 50.0% of sebaceous adenocarcinomas, and 5 of 36 patients with germline data (13.9%) carried an HRR variant. In the scoping review, 14 studies met inclusion criteria, of which 13 reported patient-level data on 41 patients. Including our case, 42 patients with 60 gene-level alterations were analyzed. BRCA1 was reported most often (38.1%), followed by BRCA2 (35.7%) and ATM (33.3%). Alterations spanned sebaceous, apocrine, eccrine, and follicular differentiation; sebaceous-lineage tumors accounted for 32 alterations (53.3%) and porocarcinoma for 18 (30.0%). Conclusion HRR alterations occur across multiple adnexal carcinoma subtypes, supporting consideration of somatic and germline testing in advanced disease. Whether these alterations predict benefit from PARP inhibition remains to be established.

Frontiers in OncologyVol. 16
Washington University in St. Louis (US)
Good health and well-being
Cancer and Skin Lesions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon